Worried about criminals hacking into your personal information? How about your phone or your computer? What if they could hack into your body? With medical devices becoming ever more data-intensive and connected, that worry is not as crazy as it sounds. Cyber security is of ever more concern to pharmaceutical biotech researchers who manage databases full of sensitive information.
Pharma and biotech companies are pushing the envelope with where they store data, how they collaborate with institutions for clinical trials, and how they build technology in medical devices.
To discuss these topics further, the BioPharma Research Council is convening Internet of Medical Things: CyberSecurity in Discovery, Development, & Devices, a symposium covering both common industry risks and IT security topics of special interest to the pharmaceutical and biotechnology community. Experts will hold a conference to help integrate the concerns of scientists, enterprise information technologists, and patients on Wednesday, July 29, from 8 a.m. to 5 p.m. at the Chauncey Hotel and Conference Center on the ETS campus on Rosedale Road. $350. Call 609-921-3600 or visit www.biopharmaresearchcouncil.org.
Topics include cybersecurity of medical devices; protecting patient data and product safety; cloud computing’s impact on security, safety, privacy, internal controls, and liability; addressing security challenges in a regulated environment; and clinical trials data protection.
Speakers include Miranda Alfonso-Williams, principal consultant of WAM Consulting Group; Colin Morgan, information security manager of Johnson & Johnson; Suzanne Schwartz, director of emergency preparedness/operations and medical countermeasures center for devices and radiological health at the FDA; Hardik Shah of Dark Matter, LifeMap Solutions, and the Mount Sinai School of Medicine; and John Wilbanks, chief commons officer of Sage Bionetworks.